15 July 1997 | Volume 127 Issue 2 | Page 170
The popularity of metformin has renewed interest in biguanide hypoglycemic agents. The association between phenformin and fatal lactic acidosis, particularly in patients with renal failure, led to the withdrawal of phenformin from the U.S. market in 1977 [1]. We describe a patient who recently died of phenformin-associated lactic acidosis.
A 64-year-old Haitian woman with diabetes, hypertension, and consequent renal insufficiency presented with profound lactic acidosis (pH, 7.15; bicarbonate level <5.0 mmol/L; lactic acid level, 54.5 mmol/L). She had been hospitalized on four previous occasions for unexplained severe lactic acidosis. After recovery from such an episode, muscle biopsy had disclosed normal structure on light and electron microscopy and normal in vitro mitochondrial enzymatic function (pyruvate dehydrogenase complex, dihydrolipoamide dehydrogenase, and electron transport chain complexes I to IV). Mitochondrial DNA contained no rearrangements or known point mutations.
During this final hospitalization, we discovered that the patient had been taking Bidiabe (Laboratori Guidotti, Pisa. Italy), a combination of chlorpropamide (125 mg) and phenformin hydrochloride (30 mg). Despite treatment with antibiotics, sodium bicarbonate, insulin, and hemodialysis, the patient died. The patient's serum phenformin concentration was 649 µg/L at admission and 42 µg/L at autopsy. Our patient had obtained Bidiabe without prescription in Haiti and had been taking it without the knowledge of her physicians for several years.
It is not known why some patients develop lactic acidosis while taking phenformin. We found no enzyme deficiency to explain recurrent acidosis in our patient. However, skeletal-muscle electron microscopy done at autopsy revealed hyperplasia of mitochondria that had normal size. internal structure, and distribution (Figure 1). Hepatocyte mitochondrial hyperplasia might reflect an early compensatory response to adverse environmental stimuli, as has been hypothesized in other settings [2]. LETTER
Fatal Phenformin-Associated Lactic Acidosis
TO THE EDITOR:
|
The availability of metformin, a drug that has similar efficacy but is associated with a lower risk for lactic acidosis, now renders phenformin obsolete [3]. Physicians, especially those serving immigrant communities, must remain aware of the availability of phenformin.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Misbin RI. Phenformin-associated lactic acidosis: pathogenesis and treatment. Ann Intern Med. 1977; 87:591-5.
2. Reznik-Schuller HM, Reuber MD. Ultrastructure of liver tumors induced in F344 rats by methapyrilene. J Environ Pathol Toxicol Oncol. 1986; 7:181-96.
3. Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996; 334:574-9.
About Letters
|
|
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
This article has been cited by other articles:
![]() |
C. A. Gallagher and A. Dobrin Risk of Suicide in Juvenile Justice Facilities: The Problem of Rate Calculations in High-Turnover Populations Criminal Justice and Behavior, October 1, 2007; 34(10): 1362 - 1376. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||